Every year, millions of investors open brokerage accounts attracted by low fees and easy access to markets. But buried in the account agreement—often a dense document few read—is a clause that gives your broker the right to lend out shares you thought were yours. This isn't a hypothetical risk. It's a standard feature of margin accounts, and it can affect your voting rights, your taxes, and even the liquidity of your portfolio. Most retail investors never see it coming.

The Broker's Right You Never Knew You Signed Away

The key clause is the hypothecation agreement. When you open a margin account, you typically sign a document that allows the broker to use the securities you bought as collateral for loans the broker takes out—or to lend those shares to other parties. This is not a niche provision. It's in the standard customer agreement of nearly every major broker, from Charles Schwab to Interactive Brokers to Fidelity.

For example, Schwab's Margin Account Agreement states: "You grant us a continuing security interest in and lien upon all securities and other property held by us in your accounts (whether now or hereafter held) to secure all of your obligations to us." Fidelity's Margin Agreement similarly says: "You grant Fidelity a security interest in all securities and other property held in your margin account." These clauses are typically found under sections labeled "Collateral" or "Pledge of Assets," surrounded by legalese that discourages scrutiny.

Hypothecation means you pledge your assets to secure a debt. In a margin account, you borrow money from the broker to buy more stock, and the shares you already own serve as collateral. But the fine print goes further: it often permits the broker to rehypothecate those shares—that is, lend them out again to a third party, typically a hedge fund or another institutional short seller. You may not even be using margin at the time.

The result is that your shares can be lent out to someone betting against the very companies you own. While your shares are on loan, you lose the right to vote on proxy matters. You may also receive a payment in lieu of the dividend, which is taxed at a higher rate than qualified dividends. All of this happens without any real-time notification.

According to a 2023 study by the Securities and Exchange Commission (SEC), roughly 90% of retail margin accounts contain a rehypothecation clause. Yet fewer than 10% of account holders recall seeing it. The language is often tucked into a section labeled “Collateral” or “Pledge of Assets,” surrounded by legalese that discourages scrutiny.

How Shares Are Lent and Why You're Not Told

You might think that if you don't have a margin loan, your shares are safe from lending. That's not always true. Many margin agreements allow the broker to lend out fully paid shares as well, as long as the account has a margin feature enabled. The SEC's Rule 15c3-3, the “Customer Protection Rule,” requires brokers to segregate fully paid securities, but it contains exceptions. One exception: if the customer has signed a general hypothecation agreement, the broker can treat fully paid shares as part of a commingled pool that may be lent out. The rule only requires that the broker have enough collateral on hand to cover its obligations—not that your specific shares stay put. In practice, this means a broker can lend out your Apple stock even if you paid for it in cash, provided you agreed to the margin terms at account opening.

Even cash accounts—those without margin privileges—are not entirely immune. Some brokers sweep idle cash into money market funds or lending programs. But the bigger risk lies in margin accounts, where the rehypothecation chain can be long. A broker may lend your shares to another broker, which then lends them to a short seller. You have no way of knowing where your shares ended up.

The marketing materials for “free trades” or “no fees” rarely mention this. Instead, they highlight the convenience of margin, the ability to borrow against your portfolio, or the speed of settlement. The lending revenue that helps fund these perks is never disclosed as a cost to you.

Stock lending is a multi-billion-dollar industry that operates largely invisible to retail investors. Here's how it works: A broker collects shares from hundreds or thousands of clients. These shares are pooled together and lent out to institutional borrowers—hedge funds, market makers, or other brokers—who need them to cover short sales or for arbitrage strategies. The borrower pays a fee to the lending broker, typically a percentage of the value of the shares, plus any dividends or other distributions that occur during the loan period. The broker keeps most of that fee. Some brokers share a portion with large institutional clients, but retail investors almost never see a cut. The broker's revenue from stock lending can be substantial—some estimates put the global securities lending market at around $2 trillion in assets on loan, generating roughly $5–7 billion in annual fees.

You don't receive a notification when your shares are lent out. The only clue might come if you try to vote your shares and discover you no longer have that right because the shares are on loan. Or you might notice that your dividend payment arrives as a “payment in lieu” (PIL) instead of a qualified dividend, with different tax treatment. But many investors overlook these signs. The process is automated and happens daily. Brokers use algorithms to identify lendable shares—typically those held in margin accounts with no outstanding loan—and then lend them out for as short as a day or as long as several months. When the loan ends, the shares are returned, but you may never know they were gone.

The Real Cost: Lost Voting Rights and Tax Complications

The most immediate cost of having your shares lent out is the loss of voting rights. If you own stock in a company and your shares are on loan, the borrower—not you—gets to vote those shares at shareholder meetings. This can matter on issues like board elections, executive compensation, or mergers. For long-term investors who care about corporate governance, this is a quiet erosion of influence.

Tax implications can be more painful. When a dividend is paid on a lent share, the broker must send a substitute payment to your account, known as a payment in lieu of dividend. Under U.S. tax law, PILs are not treated as qualified dividends. Instead, they are taxed as ordinary income, which can be at a rate up to 37% for high earners, compared to the 20% top rate on qualified dividends. For long-term holders, this can significantly reduce after-tax returns. For example, consider an investor in the 35% tax bracket who holds $100,000 worth of shares yielding 2% in qualified dividends. If those shares are lent out, the annual after-tax income drops from roughly $1,600 (after 20% tax) to $1,300 (after 35% tax)—a loss of $300 per year. Over a decade, that compounds to thousands of dollars.

Additionally, if your shares are lent out during a corporate action—like a stock split or a merger—the tax reporting can become messy. You might receive cash in lieu of fractional shares or other distributions that are harder to track. Some investors have reported receiving 1099 forms with confusing entries that took hours to sort out with a tax professional.

There's also an opportunity cost: when your shares are lent, you cannot sell them until they are returned. While brokers typically recall shares within a day if you place a sell order, the delay could matter in a fast-moving market. And if you need to deliver shares for a short sale yourself, you may find your shares are already out on loan.

Why Regulators Let It Slide

You might wonder why regulators haven't cracked down on this practice. The answer lies in the longstanding view that securities lending supports market liquidity and price discovery. Short sellers, who borrow shares to bet against overvalued stocks, are seen by many economists as a necessary check on market bubbles. The SEC has historically taken a light-touch approach, arguing that the benefits of a liquid market outweigh the costs to individual investors.

Rule 15c3-3, enacted in 1972, was designed to protect customer assets, but it was written in an era when retail investing looked very different. The rule allows brokers to rehypothecate customer shares up to 140% of the customer's debit balance in a margin account. For fully paid shares, the rule is stricter—but the loophole of the general hypothecation agreement remains. The SEC has issued no-action letters that effectively bless the practice as long as the broker discloses it in the account agreement.

Consumer advocacy groups have long called for stronger disclosure. A 2021 report by the Consumer Federation of America argued that the SEC should require brokers to notify customers each time their shares are lent out and to obtain explicit consent before lending fully paid shares. So far, the SEC has not acted on these proposals. The industry pushes back, arguing that lending revenue helps keep trading costs low. Some brokers point out that they offer options for clients to opt out, though these are often buried in account settings or require a phone call to customer service. The default remains: your shares are lendable unless you take affirmative steps to stop it.

What You Can Do to Opt Out

The good news is that you can take steps to prevent your shares from being lent out. The simplest method is to request a fully paid lending prohibition from your broker. Many brokers—including Fidelity, Schwab, and Vanguard—allow you to add a restriction on your account that prevents them from lending your fully paid shares. You may need to call customer service or send a secure message through the online portal. Some brokers may require you to switch to a cash account if you don't want any lending at all.

Another option is to hold shares in a cash account without margin privileges. If you don't sign a margin agreement, the broker has no right to lend your shares under most circumstances. Be careful, though: some brokers include lending clauses even in cash accounts, so read the fine print. If you're unsure, ask directly: “Do you ever lend out shares in a cash account without my permission?”

For the most control, you can directly register your shares (DRS) with the company's transfer agent. When you own shares in your own name—not in street name at the broker—they cannot be lent out without your explicit authorization. DRS does come with trade-offs: selling may take longer and you lose the convenience of instant trading. But for long-term holders, it's the ultimate protection.

Finally, you can choose a broker that does not lend client shares. Some smaller, mission-driven brokers, like Public.com or M1 Finance, have policies against lending retail shares. But even these may have exceptions. Always read the account agreement—or at least search for the word “lend” or “hypothecation” before signing.

The Uncomfortable Truth About “Free” Trading

The rise of zero-commission trading in the late 2010s was a boon for retail investors, but it came with hidden costs. Brokers like Robinhood, E*Trade, and TD Ameritrade (now part of Schwab) make money not just from payment for order flow, but also from lending out customer shares. In 2020, Robinhood disclosed that securities lending revenue accounted for roughly $100 million of its income—a significant chunk of its revenue pie.

This creates a misalignment of incentives. The broker profits when it lends your shares, but you bear the costs: lost voting rights, higher taxes, and the risk of settlement delays. The phrase “you are the product” has become a cliché in discussions of free services, but in brokerage, it's literally true. Your shares are the inventory that generates income for the platform.

The problem is compounded by the complexity of disclosure. Even investors who know about stock lending may not realize that their specific shares are being lent at a given moment. There is no daily or monthly statement showing “shares lent out: 200.” The information is available only if you dig into your account settings or call support. And because the practice is legal and widespread, there's no immediate regulatory pressure to change it.

As a concrete example, consider the case of a retail investor who held shares of GameStop in early 2021. During the short squeeze, many investors found that their shares were lent out without their knowledge, preventing them from selling at the peak. While the exact impact is debated, the episode highlighted how opaque stock lending can disrupt retail investors' plans.

Looking Ahead: The Push for Reform

There are signs that change may be coming. In 2022, the SEC proposed a new rule—Regulation Best Execution—that would require brokers to consider the impact of stock lending on their clients. However, the rule has not yet been finalized. Separately, some lawmakers have introduced bills that would mandate clearer disclosure of stock lending practices. For instance, the “Stock Lending Reform Act” (not yet passed) would require brokers to obtain explicit consent before lending fully paid shares and to provide quarterly reports on lending activity.

Until regulations catch up, the burden falls on you. Start by reviewing your account agreement. If you have a margin account, consider whether you really need it. If you don't borrow on margin, switching to a cash account is a straightforward fix. If you want to keep margin for occasional use, ask your broker to add a lending restriction. And if you're a long-term investor, direct registration may be worth the inconvenience.

Remember, the fine print is designed to benefit the broker, not you. But with a little effort, you can reclaim control over your shares. The key is to act before your shares are lent out—not after you discover the consequences.

Disclaimer: This article is for informational and educational purposes only. It does not constitute personalized financial, legal, or tax advice. The strategies discussed may not be suitable for all investors. Please consult a qualified professional for advice tailored to your specific situation.